Literature DB >> 11714541

Importance of weight loss definition in the prognostic evaluation of non-small-cell lung cancer.

G Buccheri1, D Ferrigno.   

Abstract

In both clinical practice and scientific reporting, various definitions of weight loss (WL) are currently in use. A comparison of their efficiency would be appropriate. In this report, we describe the first clinical evaluation of different WL definitions. New consecutive non-small-cell lung cancer (NSCLC) patients (388) were prospectively studied at the Pulmonary Unit of 'S. Croce and Carle' Hospitals from 1995 to 1999. Multiple anthropometric, clinical and pathological data, along with eight WL-related variables, were analysed. Patients' length of survival was estimated using the Kaplan-Meier function and the Cox's multivariate regression. In univariate analysis, all WL variables were prognostically significant. Among them, total WL (i.e. the percent difference between the weight at diagnosis and the last weight recorded while in good health, dichotomised by the threshold level of 11%) was the most significant factor (Log-rank: 29.65, P=0.0000). The best Cox's model for survival prediction, constructed using all the available clinical information, included, in order of importance, the following three factors: stage of disease classification, performance status and total WL. Contrary to what one might expect, WL speedy was less predictive than WL quantity. Evidence from this study suggests that, while the loss of body weight is confirmed a significant prognostic factor in NSCLC, the value of this factor is partially dependent on its definition.

Entities:  

Mesh:

Year:  2001        PMID: 11714541     DOI: 10.1016/s0169-5002(01)00273-2

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  9 in total

Review 1.  Geriatric assessment in older patients with breast cancer.

Authors:  Heidi Klepin; Supriya Mohile; Arti Hurria
Journal:  J Natl Compr Canc Netw       Date:  2009-02       Impact factor: 11.908

2.  Cancer cachexia: mechanisms and clinical implications.

Authors:  Claire L Donohoe; Aoife M Ryan; John V Reynolds
Journal:  Gastroenterol Res Pract       Date:  2011-06-13       Impact factor: 2.260

3.  Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy--a longitudinal study.

Authors:  M N Harvie; A Howell; N Thatcher; A Baildam; I Campbell
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

4.  Simplified Graded Baseline Symptom Assessment in Patients With Lung Cancer Undergoing First-Line Chemotherapy: Correlations and Prognostic Role in a Resource-Constrained Setting.

Authors:  Potsangbam Sarat Singh; Ashutosh Nath Aggarwal; Digambar Behera; Rakesh Kapoor; Navneet Singh
Journal:  J Glob Oncol       Date:  2016-05-11

5.  Proportional weight loss in six months as a risk factor for mortality in stage IV non-small cell lung cancer.

Authors:  Guilherme Watte; Claudia Helena de Abreu Nunes; Luzielio Alves Sidney-Filho; Matheus Zanon; Stephan Philip Leonhardt Altmayer; Gabriel Sartori Pacini; Marcelo Barros; Ana Luiza Schneider Moreira; Rafael José Vargas Alves; Alice de Medeiros Zelmanowicz; Bashir Mnene Matata; Jose da Silva Moreira
Journal:  J Bras Pneumol       Date:  2018 Nov-Dec       Impact factor: 2.624

6.  Measurement of mid-arm muscle circumference and prognosis in stage IV non-small cell lung cancer patients.

Authors:  Rafaela Festugatto Tartari; Jane Maria Ulbrich-Kulczynski; Antônio Fabiano Ferreira Filho
Journal:  Oncol Lett       Date:  2013-01-11       Impact factor: 2.967

7.  Poor prognosis patients with inoperable locally advanced NSCLC and large tumors benefit from palliative chemoradiotherapy: a subset analysis from a randomized clinical phase III trial.

Authors:  Hans H Strøm; Roy M Bremnes; Stein H Sundstrøm; Nina Helbekkmo; Ulf Aasebø
Journal:  J Thorac Oncol       Date:  2014-06       Impact factor: 15.609

8.  Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?

Authors:  Tom Konert; Sarah Everitt; Matthew D La Fontaine; Jeroen B van de Kamer; Michael P MacManus; Wouter V Vogel; Jason Callahan; Jan-Jakob Sonke
Journal:  PLoS One       Date:  2020-02-25       Impact factor: 3.240

9.  Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancer

Authors:  Özgür Önal; Murat Koçer; Hande Nur Eroğlu; Servet Derya Yilmaz; Ismet Eroğlu; Dilek Karadoğan
Journal:  Turk J Med Sci       Date:  2020-12-17       Impact factor: 0.973

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.